Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
$0.055
▾0.006 (9.84%)
Last trade: 29/03, 4:06PM
Market cap
$46.38m
Market closed
Investor Presentations
Principal Activity
Respiri Limited is a medical technology company developing devices and mobile health applications to improve the management of chronic, costly respiratory disorders. RSH's current generation technology has been cleared for use by the Australian TGA, has achieved the European Union CE-mark and is pending approval by the U.S. Food and Drug Administration (FDA).
Address
Level 10/446 Collins St, Melbourne VIC 3000, Australia
Website
News
Announcements
Filter
| Announcement | T+2 Movement | Date |
|---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
$0.055
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
| Company | Market Cap | ||
|---|---|---|---|
Support
Live Chat
Markets
Contact Us
(03) 9661 0441
clients@freshequities.com
Address
Level 16, 452 Flinders St
Melbourne VIC 3000
Australia